Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neuroma, Acoustic × Docosahexaenoic Acids × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Obesity 4 Sarcopenia 3 Polycystic Ovary Syndrome 3 Neoplasms 3 Melanoma 3 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Malnutrition 2 Lymphoma, Follicular 2 Colorectal Neoplasms 2 Breast Carcinoma In Situ 2 Wound Infection 1 Weight Loss 1 Urinary Bladder Neoplasms 1 Surgical Wound Infection 1 Stomach Neoplasms 1 Smoldering Multiple Myeloma 1 Skin Neoplasms 1 Psoriasis 1 Precancerous Conditions 1 Postoperative Complications 1 Polyps 1 Phagocyte Bactericidal Dysfunction 1 Pain 1 Paget's Disease, Mammary 1 Overweight 1 Osteoarthritis 1 Non-alcoholic Fatty Liver Disease 1 Neuroma, Acoustic 1

Interventions

Radiosurgery 4 Cochlear Implants 4 Gentamicins 3 Everolimus 3 Bevacizumab 3 Lapatinib 2 tozuleristide 1 neratinib 1 icotinib 1 gallium Ga 68 dotatate 1 brigatinib 1 Triamcinolone Acetonide 1 Temozolomide 1 Sufentanil 1 Sirolimus 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Mn-PyC3A 1 Methylprednisolone 1 Magnetic Resonance Spectroscopy 1 Fluoresceins 1 Fluorescein 1 Endostatins 1 Endoscopes 1 Docosahexaenoic Acids 1 Decision Support Techniques 1 Axitinib 1 Aspirin 1 AZD 6244 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05116878 2023-09-08

EFFORTS

Mayo Clinic

Phase NA Terminated

Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡